Orphan designation: xevinapant Treatment of ovarian cancer, 11/11/2015 Withdrawn | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 20 February 2025 - 14:10

Orphan designation: xevinapant Treatment of ovarian cancer, 11/11/2015 Withdrawn

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-15-1576

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters